Related Experiment Videos
PrP gene and its association with spongiform encephalopathies
1AFRC Neuropathogenesis Unit, Institute for Animal Health, Edinburgh, UK.
British Medical Bulletin
|October 1, 1993
Summary
The prion protein (PrP) gene is conserved across mammals and crucial for transmissible spongiform encephalopathies. Understanding its gene and protein biology is key to developing cures for these neurodegenerative diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- The prion protein (PrP) is central to the pathogenesis of transmissible spongiform encephalopathies (TSEs).
- PrP is a host gene product, conserved in mammals, with complex post-translational modifications.
- Its precise physiological function remains unknown, but misfolded PrP aggregates are implicated in TSEs.
Purpose of the Study:
- To review current understanding of the PrP gene and its product.
- To highlight the role of PrP in TSE pathogenesis.
- To emphasize the need for further research into PrP's molecular and cell biology for therapeutic development.
Main Methods:
- Review of existing literature on PrP gene and protein.
- Analysis of PrP gene structure, conservation, and expression patterns.
- Discussion of PrP's role in disease pathogenesis and potential therapeutic targets.
Main Results:
- The PrP gene is conserved, with transcription primarily in neurons.
- Misfolded PrP aggregates, resistant to proteolysis, are associated with TSEs.
- PrP gene polymorphisms can influence disease susceptibility, but disease-linked modifications are post-transcriptional.
Conclusions:
- Understanding the PrP gene and its product's biology is essential for TSE research.
- Further investigation is required for developing effective treatments, including gene or drug therapies.
- PrP genotype analysis offers potential for preclinical disease susceptibility inference.